Maven Securities’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.79M Buy
18,600
+7,000
+60% +$3.52M 0.17% 115
2025
Q4
$5.41M Buy
+11,600
New +$5.39M 0.12% 170
2025
Q3
Sell
-3,900
Closed -$1.49M 608
2025
Q2
$1.49M Sell
3,900
-6,900
-64% -$2.49M 0.04% 369
2025
Q1
$3.73M Buy
10,800
+4,100
+61% +$1.32M 0.11% 170
2024
Q4
$2.01M Buy
6,700
+3,600
+116% +$1.26M 0.05% 284
2024
Q3
$1.26M Sell
3,100
-300
-9% -$110K 0.02% 450
2024
Q2
$1.09M Buy
+3,400
New +$1.1M 0.02% 505
2024
Q1
Sell
-7,400
Closed -$2M 624
2023
Q4
$2M Sell
7,400
-15,600
-68% -$3.86M 0.04% 316
2023
Q3
$5.66M Buy
23,000
+20,000
+667% +$5.47M 0.06% 169
2023
Q2
$911K Buy
3,000
+1,800
+150% +$500K 0.01% 464
2023
Q1
$316K Buy
+1,200
New +$305K 0.01% 779
2022
Q2
Sell
-800
Closed -$200K 980
2022
Q1
$200K Buy
+800
New +$201K 0.01% 784
2021
Q4
Sell
-900
Closed -$218K 967
2021
Q3
$218K Buy
+900
New +$220K 0.01% 944

Other funds holding HCA

Maven Securities's HCA Position: Q1 2025 in Review

Maven Securities sold out of HCA Healthcare (HCA) in Q1 2025, closing a stake of 2,645 shares — an estimated $851K sold.

Maven Securities first reported a position in HCA in Q2 2021 and held it in 4 quarters. The position peaked at $2.68M in Q3 2023. 1,224 funds tracked by Wall St. Rank hold HCA as of Q1 2025.

  • Maven Securities reported no remaining HCA Healthcare position as of Q1 2025 after selling out during the quarter.
  • Maven Securities sold 2,645 HCA Healthcare shares in Q1 2025, an estimated $851K.
  • Maven Securities first reported a position in HCA Healthcare in Q2 2021 and held it in 4 quarters.
  • Maven Securities's HCA Healthcare position peaked at $2.68M in Q3 2023.
  • 1,224 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2025.

Based on Maven Securities's 13F filing for Q1 2025, filed 14 May 2025.